Abstract
Malignant pleural mesothelioma (MPM) is an aggressive cancer, associated with poor prognosis. We assessed the feasibility of patient-derived cell cultures to serve as an ex vivo model of MPM. Patient-derived MPM cell cultures (n=16) exhibited stemness features and reflected intratumour and interpatient heterogeneity. A subset of the cells were subjected to high-throughput drug screening and coculture assays with cancer-specific cytotoxic T cells and showed diverse responses. Some of the biphasic MPM cells were capable of processing and presenting the neoantigen SSX-2 endogenously. In conclusion, patient-derived MPM cell cultures are a promising and faithful ex vivo model of MPM.
Funder
Biomedical Research Centre
Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science
Oxfordshire Health Services Research Committee
Subject
Pulmonary and Respiratory Medicine
Reference10 articles.
1. Asbestos in Asia;Leong;Respirology,2015
2. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
3. British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
4. Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status;Kobayashi;Anticancer Res,2008
5. Establishment and preliminary characterization of human malignant mesothelioma cell lines;de Cupis;Monaldi Arch Chest Dis,1998
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献